Charles Dockendorff

Charles J.
Dockendorff currently serves as an Independent Director at Haemonetics Corp.
since 2014, an Independent Director at Keysight Technologies, Inc. since 2014, and as a Director at Management Sciences for Health, Inc. Former positions include Independent Director at Hologic, Inc. from 2017 to 2026, Independent Director at Boston Scientific Corp.
from 2015 to 2025, Director at Somanetics Corp.
from 2010 to 2011, Director at Aspect Medical Systems, Inc. from 2009 to 2011, Vice President & Controller at The Kendall Co. from 1994 to 1995, Chief Financial Officer & Executive Vice President at Covidien LP from 1995 to 2015, Chief Financial Officer at Covidien New Zealand Ltd. in 2007, Chief Financial Officer & Executive Vice President at Covidien Unlimited Co. from 1995 to 2015, Chief Financial Officer & Executive Vice President at Tyco Healthcare (Missouri) from 1995 to 2015, Chief Financial Officer, Treasurer & VP-Finance at Epsco, Inc., Chief Financial Officer & Treasurer at Infrared Industries, Inc., Principal at ev3, Inc., and Accountant roles at General Motors Corp., Ernst & Young LLP, and Arthur Young & Co. Education includes graduate studies at Bentley University and undergraduate studies at the University of Massachusetts.